1.0Public Citizenhttps://www.citizen.orgDiane Krauthamerhttps://www.citizen.org/author/dkrauthamer/Testimony on Rilonacept (ARCALYST) to the FDA's Arthritis Advisory Committee - Public Citizenrich600338<blockquote class="wp-embedded-content" data-secret="Ypk1xmTqcO"><a href="https://www.citizen.org/article/testimony-on-rilonacept-arcalyst-to-the-fdas-arthritis-advisory-committee/">Testimony on Rilonacept (ARCALYST) to the FDA’s Arthritis Advisory Committee</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.citizen.org/article/testimony-on-rilonacept-arcalyst-to-the-fdas-arthritis-advisory-committee/embed/#?secret=Ypk1xmTqcO" width="600" height="338" title="“Testimony on Rilonacept (ARCALYST) to the FDA’s Arthritis Advisory Committee” — Public Citizen" data-secret="Ypk1xmTqcO" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
Public Citizen strongly opposes the FDA’s approval of rilonacept for the prevention of gout flares because the drug provides no unique advantages over current treatment options and has known risks of serious infections and signals related to malignancies and adverse cardiovascular events.https://www.citizen.org/wp-content/uploads/public_citizen_shared_link.jpg1200628